interleukin 9 receptor
| GO Term | Evidence Code | PMID |
|---|---|---|
| immunoglobulin mediated immune response | ||
| immunoglobulin mediated immune response | ||
| cytokine-mediated signaling pathway | ||
| B cell differentiation | ||
| positive regulation of cell growth |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| plasma membrane | ||
| plasma membrane | ||
| external side of plasma membrane | ||
| cell surface |
| GO Term | Evidence Code | PMID |
|---|---|---|
| interleukin-9 receptor activity | ||
| interleukin-9 receptor activity | ||
| interleukin-9 receptor activity | ||
| interleukin-9 binding | ||
| interleukin-9 binding |
| Gene Ontology |
|---|
| cytokine-mediated signaling pathway |
| InterPro |
|---|
| Fibronectin type III superfamily |
| Fibronectin type III |
| Immunoglobulin-like fold |
| Short hematopoietin receptor, family 1, conserved site |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026